Diethyl phosphate

CAS No. 598-02-7

Diethyl phosphate( Diethyl phosphoric acid )

Catalog No. M20691 CAS No. 598-02-7

Diethyl phosphate a Non-Specific Metabolite of Organophosphorus Pesticides.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG 37 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Diethyl phosphate
  • Note
    Research use only, not for human use.
  • Brief Description
    Diethyl phosphate a Non-Specific Metabolite of Organophosphorus Pesticides.
  • Description
    Diethyl phosphate a Non-Specific Metabolite of Organophosphorus Pesticides.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Diethyl phosphoric acid
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    598-02-7
  • Formula Weight
    154.1
  • Molecular Formula
    C4H11O4P
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:34 mg/mL (220.64 mM)
  • SMILES
    CCOP(O)(=O)OCC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Yang F Li J Pang Get al.Effects of Diethyl Phosphate a Non-Specific Metabolite of Organophosphorus Pesticides on Serum Lipid Hormones Inflammation and Gut Microbiota[J].Molecules. 2019 May 24;24(10).?
molnova catalog
related products
  • Nequinate

    Nequinate is an anticoccidial agent preventing coccidiosis .

  • PF9366

    PF-9366 is a human methionine adenosyltransferase 2A (Mat2A) inhibitor (IC50: 420 nM; Kd: 170 nM).

  • Remimazolam

    Remimazolam is a benzodiazepine derivative drug as an alternative to the short-acting imidazobenzodiazepine midazolam, for use in induction of anaesthesia and conscious sedation for minor invasive procedures.?Remimazolam was found to be both faster acting and shorter lasting than midazolam, and human clinical trials showed a faster recovery time and predictable, consistent pharmacokinetics, suggesting some advantages over existing drugs for these applications.?